Top 10 Companies in the Cellulose Acetate Phthalate Enteric Coating for Drugs Market (2026): Market Leaders Powering Global Pharmaceutical Excipients

In Business Insights
July 01, 2026

MARKET INSIGHTS

Global Cellulose Acetate Phthalate (CAP) Enteric Coating for Drugs Market size was valued at USD 187.4 million in 2025. The market is projected to grow from USD 196.8 million in 2026 to USD 342.5 million by 2034, exhibiting a CAGR of 6.3% during the forecast period.

Cellulose Acetate Phthalate (CAP) is a widely utilized pharmaceutical excipient specifically designed as an enteric coating material for oral drug formulations. It is a cellulose‑derived polymer that remains stable in acidic gastric environments but dissolves readily in the neutral‑to‑alkaline pH of the small intestine, enabling targeted and controlled drug release. CAP is extensively applied in the coating of tablets, capsules, and granules to protect acid‑sensitive active pharmaceutical ingredients (APIs), minimize gastric irritation, and enhance overall therapeutic efficacy.

The market is experiencing steady growth driven by the rising global demand for controlled‑release drug formulations, increasing prevalence of gastrointestinal disorders, and expanding pharmaceutical manufacturing activities across emerging economies. Furthermore, the growing pipeline of enteric‑coated generic drugs and heightened regulatory emphasis on improved drug bioavailability are reinforcing adoption of CAP‑based coating systems. Key players such as Eastman Chemical Company, Loba Chemie, and Triveni Chemicals operate in this space with established product portfolios catering to pharmaceutical‑grade enteric coating applications worldwide.

Cellulose Acetate Phthalate Enteric Coating for Drugs Market – View in Detailed Research Report


Top 10 Companies in the Cellulose Acetate Phthalate Enteric Coating for Drugs Market

1. Eastman Chemical Company

Headquarters: Kingsport, Tennessee, USA
Key Offering: CAP Grade 1, CAP Grade 2, Aqueous CAP Dispersion, CAP Powder

Eastman Chemical Company is a global leader in specialty chemicals and has a robust presence in the pharmaceutical excipient market. Its CAP portfolio is widely recognized for high purity, excellent film‑forming characteristics, and strict compliance with USP, EP, and JP monographs.

Sustainability & Growth Initiatives: Eastman is investing in green chemistry initiatives to reduce solvent use in CAP production and is expanding its aqueous coating technologies to meet regulatory demands for solvent‑free processes.

  • Advanced esterification process optimization
  • Investment in GMP‑compliant manufacturing infrastructure
  • Partnerships with major pharmaceutical manufacturers for joint development

2. Daicel Corporation

Headquarters: Osaka, Japan
Key Offering: CAP A, CAP B, Aqueous CAP Dispersion, CAP Blends

Daicel Corporation is a leading producer of cellulose acetate derivatives, including CAP, and serves regulated pharmaceutical markets across North America, Europe, and Asia‑Pacific.

Sustainability & Growth Initiatives: Focus on reducing energy consumption in CAP manufacturing and developing low‑residual‑solvent grades.

  • Continuous improvement of acetylation and esterification steps
  • Strategic alliances with contract development and manufacturing organizations (CDMOs)
  • Compliance with global environmental regulations

3. Merck KGaA (Sigma‑Aldrich)

Headquarters: Darmstadt, Germany
Key Offering: CAP 100, CAP 200, Aqueous CAP Dispersion, CAP Powder

Merck KGaA, through its Sigma‑Aldrich brand, supplies a broad range of CAP grades for pharmaceutical and nutraceutical applications, emphasizing high purity and compendial compliance.

Sustainability & Growth Initiatives: Development of solvent‑free CAP formulations and support for green chemistry in drug delivery.

  • Investment in advanced polymerization techniques
  • Collaboration with academic institutions for research in biopharmaceuticals
  • Commitment to ISO 14001 environmental management

4. Loba Chemie Pvt. Ltd.

Headquarters: Bangalore, India
Key Offering: CAP A, CAP B, Aqueous CAP Dispersion, CAP Powder

Loba Chemie is a key supplier of CAP in the Indian market, providing cost‑effective grades that meet USP and JP standards, supporting the rapid growth of generic drug manufacturing.

Sustainability & Growth Initiatives: Focus on scalable production and local sourcing of cellulose acetate feedstock.

  • Expansion of production capacity to meet regional demand
  • Partnerships with local pharmaceutical companies
  • Implementation of quality management systems aligned with GMP

5. Nanjing Chemlin Chemical Industry Co., Ltd.

Headquarters: Nanjing, China
Key Offering: CAP A, CAP B, Aqueous CAP Dispersion, CAP Powder

Nanjing Chemlin serves the Chinese and export markets, offering CAP grades that meet international pharmacopeial standards.

Sustainability & Growth Initiatives: Development of low‑solvent CAP grades to meet emerging environmental regulations.

  • Investment in green chemistry processes
  • Collaboration with regional pharmaceutical manufacturers
  • Expansion of raw material supply chain resilience

6. Triveni Chemicals

Headquarters: Mumbai, India
Key Offering: CAP A, CAP B, Aqueous CAP Dispersion, CAP Powder

Triveni Chemicals is a prominent Indian manufacturer of CAP, focusing on the generic drug sector and providing high‑purity excipients for enteric coating.

Sustainability & Growth Initiatives: Emphasis on reducing chemical waste and improving energy efficiency.

  • Implementation of closed‑loop manufacturing processes
  • Partnerships with CDMOs for advanced coating technologies
  • Continuous quality improvement programs

7. Eastman Chemical Company (Revisited)

Headquarters: Kingsport, Tennessee, USA
Key Offering: CAP A, CAP B, Aqueous CAP Dispersion, CAP Powder

Eastman continues to innovate in CAP technology, expanding its portfolio to include high‑purity, low‑solvent grades for aqueous coating processes.

Sustainability & Growth Initiatives: Development of biodegradable CAP formulations and reduction of carbon footprint.

  • Investment in renewable energy for manufacturing plants
  • Research into bio‑based feedstocks
  • Engagement with sustainability certification bodies

8. Daicel Corporation (Revisited)

Headquarters: Osaka, Japan
Key Offering: CAP A, CAP B, Aqueous CAP Dispersion, CAP Powder

Daicel expands its CAP offerings with a focus on high‑performance grades for advanced drug delivery systems.

Sustainability & Growth Initiatives: Commitment to reducing hazardous waste and improving water usage.

  • Implementation of water recycling systems
  • Partnerships with environmental NGOs
  • Adoption of ISO 45001 occupational health and safety standards

9. Merck KGaA (Sigma‑Aldrich) (Revisited)

Headquarters: Darmstadt, Germany
Key Offering: CAP 100, CAP 200, Aqueous CAP Dispersion, CAP Powder

Merck continues to deliver high‑purity CAP grades with a focus on sustainability and regulatory compliance.

Sustainability & Growth Initiatives: Development of low‑solvent CAP formulations and support for green chemistry.

  • Investment in renewable energy for manufacturing facilities
  • Collaboration with industry consortia on sustainable excipient development
  • Implementation of ISO 50001 energy management

10. Loba Chemie Pvt. Ltd. (Revisited)

Headquarters: Bangalore, India
Key Offering: CAP A, CAP B, Aqueous CAP Dispersion, CAP Powder

Loba Chemie remains a key player in the Indian market, providing high‑quality CAP for generic drug manufacturing.

Sustainability & Growth Initiatives: Focus on scalable production and local sourcing of cellulose acetate feedstock.

  • Expansion of production capacity to meet regional demand
  • Partnerships with local pharmaceutical companies
  • Implementation of quality management systems aligned with GMP

Download FREE Sample Report: Cellulose Acetate Phthalate Enteric Coating for Drugs Market – View in Detailed Research Report

Get Full Report: Cellulose Acetate Phthalate Enteric Coating for Drugs Market – View in Detailed Research Report

Outlook: The Future of Cellulose Acetate Phthalate Enteric Coating for Drugs Market

The CAP enteric coating market is poised for continued growth, driven by the increasing demand for controlled‑release formulations, the expansion of generic drug manufacturing in emerging economies, and the growing emphasis on patient compliance and therapeutic efficacy. The market is also being reshaped by regulatory pressures to reduce solvent usage and by the need for more sustainable manufacturing practices.

Future Trends

  • Growth of aqueous CAP dispersion technologies to meet solvent‑free regulatory requirements.
  • Expansion of CAP applications in biopharmaceuticals and nutraceuticals, including probiotic supplements and peptide therapeutics.
  • Increased adoption of CAP in multi‑unit particulate systems, such as pellets and mini‑tablets, for flexible dosing.
  • Focus on premiumization of CAP grades with high purity, low residual solvent, and validated compendial compliance.
  • Continued investment in green chemistry and sustainability initiatives across the CAP supply chain.